Largest clinical trial for blood cancer that has spread to brain shows new treatment regime dramatically improves survival for some patients
The largest ever clinical trial looking at the best way to treat lymphoma if it…
Browsing: Lymphoma
A potent weapon against lymphomas
Researchers from the The Max Delbrück Center (MDC) for Molecular Medicine in the Helmholtz Association…
HIV positive and negative patients with lymphoma as a predictor of outcome and tumour proliferation
This authors of a new paper published in Oncotarget reported that the aim of this study is…
Researchers discover potential new drug target to treat cutaneous T cell lymphoma
Cutaneous T cell lymphomas (CTCLs) are a group of non-Hodgkin lymphomas that develop from T…
ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…
ASH 2020: CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels…
Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma
The histone deacetylase (HDAC) inhibitor vorinostat (Zolinza) in combination with the mTOR inhibitor sirolimus (Rapamune)…
Many Non-Hodgkin’s Lymphoma patients can skip radiation, collaborative study finds
Skipping radiation and receiving less chemotherapy may become the new standard of care for some…
New therapeutic target identified for rare virus-associated lymphomas
Targeting a “cell survival” protein could be a valuable new approach to treating certain blood…
Study identifies characteristics of infused CAR-T cells associated with efficacy and toxicity in patients with large B-cell lymphoma
Researchers at The University of Texas MD Anderson Cancer Center, USA, have identified molecular and…